X4 PHARMACEUTICALS, INC Inventory, Raw Materials, Gross
X4 PHARMACEUTICALS, INC (XFOR) had Inventory, Raw Materials, Gross of $1.58 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Inventory › Inventory, Gross
us-gaap:InventoryRawMaterials · last filed 2026-08-06
- 2026-06-30: Inventory, Raw Materials, Gross $1.58M.
- 2026-03-31: Inventory, Raw Materials, Gross $1.43M.
- 2025-12-31: Inventory, Raw Materials, Gross $1.38M.
- 2025-09-30: Inventory, Raw Materials, Gross $1.40M.
| Period end | Inventory, Raw Materials, Gross |
|---|---|
| 2026-06-30 | $1.58M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $1.43M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $1.38M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $1.40M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $1.53M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $1.53M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $1.53M 10-K · filed 2026-03-17 |
| 2024-09-30 | $1.52M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $612.00K 10-Q · filed 2024-08-08 |
| 2023-12-31 | $0.00 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |